Efficacy and safety of laser-assisted delivery of tranexamic acid for the treatment of melasma: a systematic review and meta‑analysis

References

• Kwon S, Park K. Melasma and common pigmentary dermatoses in Asian individuals and an overview of their treatment. J Clin Investigat Dermatol. 2014;2(1):8.
   Google Scholar
• Spierings NM. Melasma: a critical analysis of clinical trials investigating treatment modalities published in the past 10 years. J Cosmet Dermatol. 2020;19(6):1284–89.doi:10.1111/jocd.13182.
   PubMed Web of Science ®Google Scholar
• Lieu TJ, Pandya AG. Melasma quality of life measures. Dermatol Clin. 2012;30(2):269–80.doi:10.1016/j.det.2011.11.009.
   PubMed Web of Science ®Google Scholar
• Zhang L, Tan W-Q, Fang -Q-Q, Zhao W-Y, Zhao Q-M, Gao J, Wang X-W. Tranexamic acid for adults with melasma: a systematic review and meta-analysis. Biomed Res Int. 2018;2018:1–13.
   Web of Science ®Google Scholar
• Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999;57(6):1005–32. doi:10.2165/00003495-199957060-00017. published Online First: 1999/07/10.
   PubMed Web of Science ®Google Scholar
• Perper M, Eber AE, Fayne R, Verne SH, Magno RJ, Cervantes J, ALharbi M, ALOmair I, Alfuraih A, Nouri K. Tranexamic acid in the treatment of melasma: a review of the literature. Am J Clin Dermatol. 2017;18(3):373–81.doi:10.1007/s40257-017-0263-3.
   PubMed Web of Science ®Google Scholar
• Basit A, Rahman A, Uddin R. oral tranexemic acid with triple combination cream (flucinolone+ hydroquinone+ tretinoin) versus triple combination cream alone in treatment of melasma. Journal of Ayub Medical College, Abbottabad: JAMC. 2021;33(2):293–98.
   PubMedGoogle Scholar
• Na J, Choi S, Yang S, Choi HR, Kang HY, Park K-C. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. Journal of the European Academy of Dermatology and Venereology. 2013;27(8):1035–39.doi:10.1111/j.1468-3083.2012.04464.x.
   PubMed Web of Science ®Google Scholar
• Hauck WW. Bioequivalence studies of topical preparations: statistical considerations. Int J Dermatol. 1992;31:29–33.doi:10.1111/j.1365-4362.1992.tb04010.x.
   PubMed Web of Science ®Google Scholar
• Searle T, Ali FR, Al-Niaimi F. Lessons learned from the first decade of laser-assisted drug delivery. Dermatol Ther (Heidelb). 2021;11(1):93–104.doi:10.1007/s13555-020-00478-5.
   PubMed Web of Science ®Google Scholar
• Alegre-Sánchez A, Jiménez-Gómez N, Boixeda P. Laser-assisted drug delivery. Actas Dermo-Sifiliograficas (English Edition). 2018;109(10):858–67.doi:10.1016/j.adengl.2018.10.012.
   Google Scholar
• Higgins JP, Thomas J, Chandler J. Cochrane handbook for systematic reviews of interventions. West Sussex, England: John Wiley & Sons; 2019.
   Google Scholar
• Kimbrough-Green CK, Griffiths CE, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, Voorhees JJ. Topical retinoic acid (tretinoin) for melasma in black patients: a vehicle-controlled clinical trial. Arch Dermatol. 1994;130(6):727–33.doi:10.1001/archderm.1994.01690060057005.
   PubMedGoogle Scholar
• Pandya AG, Hynan LS, Bhore R, Riley FC, Guevara IL, Grimes P, Nordlund JJ, Rendon M, Taylor S, Gottschalk RW, et al. Reliability assessment and validation of the Melasma Area And Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol. 2011;64(1):78–83. e2.doi:10.1016/j.jaad.2009.10.051.
   PubMed Web of Science ®Google Scholar
• Sirithanabadeekul P, Srieakpanit R. Intradermal tranexamic acid injections to prevent post-inflammatory hyperpigmentation after solar lentigo removal with a Q-switched 532-nm Nd:YAG laser. J Cosmet Laser Ther. 2018;20(7–8):398–404. doi:10.1080/14764172.2018.1444770. published Online First: 2018/03/06.
   PubMed Web of Science ®Google Scholar
• Hsiao CY, Huang CH, Hu S, Ko YS, Sung HC, Chen CC, Huang SY. F ractional C arbon D ioxide L aser T reatment to E nhance S kin P ermeation of A scorbic A cid 2‐G lucoside with M inimal S kin D isruption. Dermatologic Surgery. 2012;38(8):1284–93.doi:10.1111/j.1524-4725.2012.02454.x.
   PubMedGoogle Scholar
• Jalaly NY, Valizadeh N, Barikbin B, Yousefi M. Low-power fractional CO2 laser versus low-fluence Q-switch 1,064 nm Nd: YAG laser for treatment of melasma: a randomized, controlled, split-face study. Am J Clin Dermatol. 2014;15(4):357–63.doi:10.1007/s40257-014-0080-x.
   PubMed Web of Science ®Google Scholar
• Qu Y, Wang F, Liu J, Xia X. Clinical observation and dermoscopy evaluation of fractional CO 2 laser combined with topical tranexamic acid in melasma treatments. J Cosmet Dermatol. 2021;20(4):1110–16.doi:10.1111/jocd.13992.
   PubMed Web of Science ®Google Scholar
• Tawfic SO, Abdel Halim DM, Albarbary A, Abdelhady M. Assessment of combined fractional CO 2 and tranexamic acid in melasma treatment. Lasers Surg Med. 2019;51(1):27–33.doi:10.1002/lsm.23032.
   PubMed Web of Science ®Google Scholar
• Cho SB, Goo BL, Zheng Z, Yoo KH, Kang J-S, Kim H. Therapeutic efficacy and safety of a 1927-nm fractionated thulium laser on pattern hair loss: an evaluator-blinded, split-scalp study. Lasers Med Sci. 2018;33(4):851–59.doi:10.1007/s10103-018-2437-5.
   PubMed Web of Science ®Google Scholar
• Lee HM, Haw S, Kim JK, Chang SE, Lee MW. Split-face study using a 1,927-nm thulium fiber fractional laser to treat photoaging and melasma in Asian skin. Dermatol Surg. 2013;39(6):879–88. doi:10.1111/dsu.12176. published Online First: 2013/03/08.
   PubMed Web of Science ®Google Scholar
• Chun S. Fractional microneedling radiofrequency and fractional 1927 nm thulium laser treatment offer synergistic skin rejuvenation: a pilot case series. Laser Therapy. 2018;27(4):283–91.
   PubMedGoogle Scholar
• Wanitphakdeedecha R, Sy-Alvarado F, Patthamalai P, Techapichetvanich T, Eimpunth S, Manuskiatti W. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study. Lasers Med Sci. 2020;35(9):2015–21.doi:10.1007/s10103-020-03045-8.
   PubMed Web of Science ®Google Scholar
• Lipozenčić J, Mokos ZB. Will nonablative rejuvenation replace ablative lasers? Facts and controversies. Clin Dermatol. 2013;31(6):718–24. doi:10.1016/j.clindermatol.2013.05.008. published Online First: 2013/10/29.
   PubMed Web of Science ®Google Scholar
• Omi T, Yamashita R, Kawana S, Sato S, Naito Z. Low fluence q-switched nd: yag laser toning and q-switched ruby laser in the treatment of melasma:a comparative split-face ultrastructural study. Laser Ther. 2012;21(1):15–4. doi:10.5978/islsm.12-OR-03. published Online First: 2012/03/28.
   PubMedGoogle Scholar
• Laothaworn V, Juntongjin P. Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma. Journal of Cosmetic and Laser Therapy. 2018;20(6):320–25.doi:10.1080/14764172.2018.1427869.
   PubMed Web of Science ®Google Scholar
• Observation on the effect of Nd: YAG 1064nm laser combined with topical tranexamic acid on chloasma. 2020 International Conference on Public Health and Data Science (ICPHDS) Guangzhou, China; 2020. IEEE.
   Google Scholar